← All trials
NCT01772940
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2008
- Primary completion
- Oct 1, 2011
- Completion date
- Dec 1, 2011
- First posted
- —
- Last posted
- —
- Enrollment
- 425
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- Free University of BrusselsLead sponsor
- Free University of BrusselsOverall official - principal investigator
- AbbottCollaborator
- Pierre and Marie Curie UniversityCollaborator
- Gilead SciencesCollaborator
- University of LiegeCollaborator
- University of ParisCollaborator
- Free University of BrusselsReponsible party - principal investigator
- Government of the Democratic Republic of the CongoCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.